Marcio Souza - Jun 18, 2021 Form 3 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Director
Signature
/s/ Steven Weber, by power of attorney
Stock symbol
AGLE
Transactions as of
Jun 18, 2021
Transactions value $
$0
Form type
3
Date filed
6/22/2021, 04:06 PM
Next filing
Aug 19, 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.